Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
327 studies found for:    mesothelioma
Show Display Options
Rank Status Study
1 Unknown  Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Condition: Mesothelioma
Intervention:
2 Completed Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma
Condition: Mesothelioma
Intervention: Behavioral: Questionnaires & online virtual support group
3 Completed Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays
Condition: Peritoneal Mesothelioma
Intervention: Genetic: comparative genomic analysis
4 Recruiting Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma;   Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Methotrexate;   Drug: Gemcitabine;   Other: Lung Cancer Symptom Scale for Mesothelioma Questionnaire
5 Active, not recruiting
Has Results
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Conditions: Pleural Mesothelioma;   Peritoneal Mesothelioma
Intervention: Drug: IMC-A12
6 Active, not recruiting Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: HSV1716 Intra-pleural delivery
7 Completed
Has Results
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: everolimus
8 Completed Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Imatinib Mesylate;   Drug: Pemetrexed;   Drug: Dexamethasone
9 Recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention:
10 Unknown  Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
Conditions: Mesothelioma;   Lung Cancer
Intervention:
11 Completed Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)
Condition: Malignant Pleural Mesotheliomas
Intervention: Other: marker CD74 and vascular endothelial growth factor VEGF
12 Recruiting Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma
Conditions: Lung Cancer;   Mesothelioma
Interventions: Procedure: Low-dose computed tomography Annual scan x3;   Procedure: Low-dose computed tomography Baseline scan only
13 Active, not recruiting SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Conditions: Mesothelioma;   Adenocarcinoma of Lung;   Pancreatic Neoplasms
Interventions: Drug: Pentostatin;   Drug: Cyclophosphamide;   Biological: SS1(dsFv)PE38 - lot 073I0809;   Biological: SS1(dsFv)PE38 - lot FIL129J01
14 Completed Serum Biomarkers in Diagnosis of Mesothelioma
Condition: Mesothelioma
Intervention: Biological: Mesothelin, hyaluronan, osteopontin, syndecan-1
15 Completed
Has Results
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: dasatinib
16 Not yet recruiting Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Concurrent Durvalumab;   Drug: Maintenance Durvalumab
17 Completed Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Erlotinib;   Drug: Bevacizumab
18 Completed An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention: Drug: ZD1839
19 Completed Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)
Condition: Peritoneal Mesotheliomas
Intervention: Procedure: Cytoreductive surgery and HIPEC
20 Terminated Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: defactinib (VS-6063);   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years